We Improve the Discoverability of Press Releases
NewsRamp™ is the PR and Newswire technology platform that transforms press releases into AI-optimized and multi-modal unique content formats designed to maximize discovery, engagement and global reach. NewsRamp™ primarily services newswires and news publishers.
Latest News
LIXTE Biotech Targets 'Cold' Tumors with New Immunotherapy Enhancer
about 3 hours ago
Beeline's AI Mortgage Platform Redefines Digital Home Financing
about 3 hours ago
LIXTE Acquires Liora, Forging New Cancer Care Ecosystem
about 6 hours ago
Property Management's Netflix Moment: AI Aligns Incentives
about 6 hours ago
HR News
GVT Unveils Major FAMCare Upgrades for Human Services Agencies
about 15 hours ago
HR.com Announces 2026 Leadership Development Award Winners
5 days ago
Global Hiring Accelerates Amid AI Reshaping and Engagement Strain in 2026
6 days ago
Fractional HR: Texas's Answer to Growth & Compliance Risks
12 days ago
HR.com Honors Top CHROs and Women Leaders in 2026 Awards
12 days ago
Business News
OS Therapies' Osteosarcoma Treatment Advances Toward FDA Approval
in 7 months
OS Therapies Advances Breakthrough Osteosarcoma Treatment Toward Approval
in 7 months
Cingulate's ADHD Drug CTx-1301 Advances Toward 2026 FDA Decision
in 3 months
Branicks Seeks Loan Extension Amid Strong Operational Performance
19 minutes ago
GEA Reports Record Growth, Hits Climate Goals Early, Enters DAX
31 minutes ago
Crypto News
Bitcoin Bancorp to Present at NIBA Conference, Showcasing ATM Network Expansion
about 10 hours ago
Crypto Market Slide in 2026: Grayscale Sees Long-Term Opportunity Amid Downturn
3 days ago
Utexo Raises $7.5M to Enable Bitcoin-Native USDT Settlement
3 days ago
Forward Industries Holds 6.97M SOL, Achieves 6.73% APY in Solana Treasury
4 days ago
Bitcoin Holds Steady Amid Middle East Tensions, Key for MicroStrategy
4 days ago
Health News
OS Therapies' Osteosarcoma Treatment Advances Toward FDA Approval
in 7 months
OS Therapies Advances Breakthrough Osteosarcoma Treatment Toward Approval
in 7 months
Cingulate's ADHD Drug CTx-1301 Advances Toward 2026 FDA Decision
in 3 months
HeartBeam Showcases Revolutionary 3D ECG Tech at Major 2026 Conferences
about 2 hours ago
LIXTE Biotech Targets 'Cold' Tumors with New Immunotherapy Enhancer
about 3 hours ago
Technology News
GEA Reports Record Growth, Hits Climate Goals Early, Enters DAX
31 minutes ago
HeartBeam Showcases Revolutionary 3D ECG Tech at Major 2026 Conferences
about 2 hours ago
Beeline's AI Mortgage Platform Redefines Digital Home Financing
about 3 hours ago
Hong Kong Entertainment Expo 2026: A Global Hub for Film, AI, and Cultural Exchange
about 5 hours ago
Property Management's Netflix Moment: AI Aligns Incentives
about 6 hours ago
Events & Conferences
HeartBeam Showcases Revolutionary 3D ECG Tech at Major 2026 Conferences
about 2 hours ago
Hong Kong Entertainment Expo 2026: A Global Hub for Film, AI, and Cultural Exchange
about 5 hours ago
SPARC Health Announces 12 Finalists for 2026 Life Sciences Pitch Competition
about 6 hours ago
TheLinkU & Twitch Launch StreamU: Exclusive College Sports Livestream Network
about 8 hours ago
Octane Announces Neuro Tech Forum 2026 to Advance Neurotechnology Innovation
about 8 hours ago